Gail Model for 5 Year Risk of Breast Cancer (1999 paper) À¯¹æ¾Ï 5³â »ýÁ¸·ü

Relative_Risk = AGEMEN * NBIOPS * AGEFLB_NUMREL * AHYPER
Five_Year_Risk = Relative_Risk * BASELINE_AGE_RACE

ÀԷ°ª:

AGEMEN ÃÊ°æ ¿¬·É >= 14¼¼ (1.00)

12-13 ¼¼ (1.10)

< 12 ¼¼ (1.21)
NBIOPS
AGEFLB_NUMREL
AHYPER »ý°Ë ¾ÈÇÔ (1.00)

ÃÖ¼Ò 1¹ø ÀÌ»ó »ý°ËÇÏ¿´À¸¸ç ¾î¶² Á¶Á÷¿¡¼­µµ ºñÁ¤Çü Áõ½Ä(atypical hyperplasia)¼Ò°ß ¾øÀ½ (0.93)

ºñÁ¤Çü Áõ½ÄÀº °üÂûµÇÁö ¾Ê¾ÒÀ¸³ª, ÃÖ¼ÒÇÑ 1°³ ÀÌ»óÀÇ Á¶Á÷¿¡¼­ Áõ½Ä »óŸ¦ ¸ð¸§ (1.00)

ÃÖ¼ÒÇÑ ÇѰ³ÀÇ Á¶Á÷¿¡¼­ ºñÁ¤Çü Áõ½ÄÀÌ ¹ß°ßµÊ (1.82)
BASELINE_AGE_RACE

°á°ú°ª:

Relative_Risk
Five_Year_Risk
 
Decimal Precision:

¸ðµç Ç®´Ù¿î ¸Þ´º¸¦ ¼±ÅÃÇß´ÂÁö È®ÀÎÇϼ¼¿ä.


Âü°í¹®Çå

Gail MH, Constantino JP, Bryant J, et. al., Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer, J. National Cancer Institute, V91, #21, pages 1829-1846.

MedCalc CrossRef: Gail Model (1989 paper)

MedCalc CrossRef: Odds Ratio and Relative Risk

MedCalc CrossRef: Breast Cancer Local Recurrence Risk

 


¹ýÀû °øÁö ¹× ¸éÃ¥

¸ÞµåĮũ 3000¿¡ Æ÷ÇÔµÇ°í ¸¸µé¾îÁø ¸ðµç Á¤º¸´Â ±³À°Àû ¸ñÀû¸¸À» À§ÇØ Á¦°øµË´Ï´Ù. ÀÌ Á¤º¸´Â ¾î¶°ÇÑ °Ç°­»óÀÇ ¹®Á¦³ª Áúº´À» Áø´ÜÇϰųª Ä¡·áÇϴµ¥ »ç¿ëµÇ¾î¼­´Â ¾ÈµË´Ï´Ù. ¿ì¸®´Â ÀÌ Á¤º¸¸¦ ¾î¶² ÇüÅÂ·Îµç °³°³ÀΠȯÀÚ¸¦ µ¹º¸´Â ÁöħÀ̳ª ÀÓ»óÀû ÆÇ´ÜÀ» ´ë½ÅÇÒ Àǵµ·Î ¸¸µéÁö ¾Ê¾Ò½À´Ï´Ù. ¹ýÀû °øÁö ¹× ¸éÃ¥ÀÇ Àü¹®À» º¸·Á¸é ¿©±â¸¦ Ŭ¸¯Çϼ¼¿ä.
 

MedCalc 3000 is Copyright © 1998-2005 Foundation Internet Services